{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T06:38:24Z","timestamp":1774334304102,"version":"3.50.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiology Clinics"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ccl.2024.01.007","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T21:34:38Z","timestamp":1709242478000},"page":"497-507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Migraine Headache and Patent Foramen Ovale"],"prefix":"10.1016","volume":"42","author":[{"given":"Robert J.","family":"Sommer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara T.","family":"Robbins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ccl.2024.01.007_bib1","doi-asserted-by":"crossref","first-page":"e293","DOI":"10.1097\/j.pain.0000000000002275","article-title":"Global, regional, and national burden of migraine in 204 countries and territories, 1990 to 2019","volume":"163","author":"Safiri","year":"2022","journal-title":"Pain"},{"key":"10.1016\/j.ccl.2024.01.007_bib2","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"issue":"Suppl 15","key":"10.1016\/j.ccl.2024.01.007_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/J.1468-2982.1995.TB00040.X","article-title":"The history of migraine from Mesopotamian to medieval times","author":"Clifford Rose","year":"1995","journal-title":"Cephalalgia"},{"key":"10.1016\/j.ccl.2024.01.007_bib4","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/0002-9149(66)90056-7","article-title":"The prophylactic value of propranolol in angina pectoris","volume":"18","author":"Rabkin","year":"1966","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.ccl.2024.01.007_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11940-012-0208-3","article-title":"Familial and sporadic hemiplegic migraine: diagnosis and treatment","volume":"15","author":"Pelzer","year":"2013","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.ccl.2024.01.007_bib6","first-page":"421","article-title":"Botox for migraine: double-bind, placebo-controlled region-specific evaluation","volume":"20","author":"Brin","year":"2000","journal-title":"Cephalalgia"},{"key":"10.1016\/j.ccl.2024.01.007_bib7","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1526-4610.2000.00066.x","article-title":"Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group","volume":"40","author":"Silberstein","year":"2000","journal-title":"Headache"},{"key":"10.1016\/j.ccl.2024.01.007_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003226.pub2","article-title":"Anticonvulsant drugs for migraine prophylaxis","volume":"3","author":"Chronicle","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ccl.2024.01.007_bib9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.289.1.65","article-title":"Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial","volume":"289","author":"Tronvik","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2024.01.007_bib10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11916-003-0010-8","article-title":"Antidepressants in the treatment of migraine headache","volume":"7","author":"Punay","year":"2003","journal-title":"Curr Pain Headache Rep"},{"issue":"8","key":"10.1016\/j.ccl.2024.01.007_bib11","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1177\/1060028020903417","article-title":"Calcitonin gene-related peptide antagonists for the prevention of migraine: highlights from pivotal studies and the clinical relevance of this new drug class","volume":"54","author":"Arca","year":"2020","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ccl.2024.01.007_bib12","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1523\/JNEUROSCI.0373-15.2015","article-title":"Migraine: multiple Processes, complex pathophysiology","volume":"35","author":"Burstein","year":"2015","journal-title":"J\u00a0Neuroscience"},{"key":"10.1016\/j.ccl.2024.01.007_bib13","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/bmj.310.6983.830","article-title":"Case-control study of migraine and risk of ischaemic stroke in young women","volume":"310","author":"Tzourio","year":"1995","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.ccl.2024.01.007_bib14","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/0895-4356(89)90075-9","article-title":"A\u00a0controlled study of ischemic stroke risk in migraine patients","volume":"42","author":"Henrich","year":"1989","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.ccl.2024.01.007_bib15","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJM198805053181802","article-title":"Prevalence of patent foramen ovale in patients with stroke","volume":"318","author":"Lechat","year":"1988","journal-title":"NEJM"},{"key":"10.1016\/j.ccl.2024.01.007_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0140-6736(88)92944-3","article-title":"Patent foramen ovale in young stroke patients","volume":"2","author":"Webster","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2024.01.007_bib17","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1212\/WNL.52.8.1622","article-title":"Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study","volume":"52","author":"Anzola","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.ccl.2024.01.007_bib18","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1468-2982.2008.01554.x","article-title":"Patent foramen ovale and migraine: a quantitative systematic review","volume":"28","author":"Schwedt","year":"2008","journal-title":"Cephalalgia"},{"key":"10.1016\/j.ccl.2024.01.007_bib19","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.amjcard.2007.08.047","article-title":"Prevalence of migraine headache in patients with congenital heart disease","volume":"101","author":"Truong","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccl.2024.01.007_bib20","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1183\/09031936.00179008","article-title":"Pulmonary arteriovenous malformations associated with migraine with aura","volume":"34","author":"Post","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccl.2024.01.007_bib21","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/S0140-6736(00)03160-3","article-title":"Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons","volume":"356","author":"Wilmshurst","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2024.01.007_bib22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1540-8183.2003.08001.x","article-title":"Transcatheter closure of patent foramen ovale: a new migraine treatment?","volume":"16","author":"Morandi","year":"2003","journal-title":"J\u00a0Int Cardiol"},{"key":"10.1016\/j.ccl.2024.01.007_bib23","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1212\/01.WNL.0000120677.64217.A9","article-title":"Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks","volume":"62","author":"Schwerzmann","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.ccl.2024.01.007_bib24","doi-asserted-by":"crossref","first-page":"922.e1","DOI":"10.1016\/j.ahj.2005.09.019","article-title":"Transcatheter patent foramen ovale closure mitigates aura migraine headaches abolishing spontaneous right-to-left shunting","volume":"151","author":"Giardini","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.ccl.2024.01.007_bib25","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jacc.2004.10.055","article-title":"Migraine headache relief after transcatheter closure of patent foramen ovale","volume":"45","author":"Reisman","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2024.01.007_bib26","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.amjcard.2006.12.054","article-title":"Five-year experience with percutaneous closure of patent foramen ovale","volume":"99","author":"Slavin","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccl.2024.01.007_bib27","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/ccd.21025","article-title":"Is patent foramen ovale closure effective in reducing migraine symptoms? A controlled study","volume":"69","author":"Kimmelstiel","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ccl.2024.01.007_bib28","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.amjcard.2009.03.061","article-title":"Usefulness of transcatheter patent foramen ovale closure in migraineurs with moderate to large right-to-left shunt and instrumental evidence of cerebrovascular damage","volume":"104","author":"Papa","year":"2009","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.ccl.2024.01.007_bib29","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/hrt.2009.181156","article-title":"Improvement of migraine headaches after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism","volume":"96","author":"Wahl","year":"2010","journal-title":"Heart"},{"issue":"6","key":"10.1016\/j.ccl.2024.01.007_bib30","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jcin.2012.03.013","article-title":"The effect of patent foramen ovale closure on visual aura without headache or typical aura with migraine headache","volume":"5","author":"Khessali","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ccl.2024.01.007_bib31","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1161\/CIRCULATIONAHA.107.727271","volume":"117","author":"Dowson","year":"2008","journal-title":"Circulation"},{"issue":"26","key":"10.1016\/j.ccl.2024.01.007_bib33","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/eurheartj\/ehw027","article-title":"Percutaneous closure of patent foramen ovale in migraine with aura: a randomized controlled trial","volume":"37","author":"Mattle","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccl.2024.01.007_bib34","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1016\/j.jacc.2017.09.1105","article-title":"Percutaneous closure of patent foramen ovale in patients with migraine: the PREMIUM Trial","volume":"70","author":"Tobis","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2024.01.007_bib35","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jacc.2020.11.068","article-title":"Pooled analysis of PFO occluder device trials in patients with PFO and migraine","volume":"77","author":"Mojadidi","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2024.01.007_bib36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000229194","article-title":"Biochemical investigations in headache: increase in Hydroxyindoleactic Acid Excretion during migraine attacks","volume":"19","author":"Sicuteri","year":"1961","journal-title":"Int Arch Allergy Appl Immun"},{"key":"10.1016\/j.ccl.2024.01.007_bib37","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/jnnp.35.4.505","article-title":"5-Hydroxytryptamine levels and platelet aggregation responses in subjects with acute migraine headache","volume":"35","author":"Hilton","year":"1972","journal-title":"J\u00a0Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/j.ccl.2024.01.007_bib38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1526-4610.1977.hed1703101.x","article-title":"Cyclic changes in platelet dynamics and the pathogenesis and prophylaxis of migraine","volume":"17","author":"Deshmukh","year":"1977","journal-title":"Headache"},{"key":"10.1016\/j.ccl.2024.01.007_bib39","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0140-6736(78)92222-5","article-title":"Migraine: a blood disorder?","volume":"2","author":"Hanington","year":"1978","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ccl.2024.01.007_bib40","first-page":"87","article-title":"Migraine or transient ischemic attacks in a patient with essential thrombocythaemia. Treatment with ticlopidine","volume":"131","author":"Bousser","year":"1980","journal-title":"Ann Med Interne"},{"key":"10.1016\/j.ccl.2024.01.007_bib41","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0140-6736(78)91534-9","article-title":"Dipyridamole in migraine","volume":"2","author":"Hawkes","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2024.01.007_bib42","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1526-4610.1976.hed1603129.x","article-title":"Use of platelet antagonists in the treatment of migraine","volume":"16","author":"Dalessio","year":"1976","journal-title":"Headache"},{"key":"10.1016\/j.ccl.2024.01.007_bib43","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0140-6736(78)91488-5","article-title":"Success of failure of dipyridamole in migraine","volume":"2","author":"Damasio","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2024.01.007_bib44","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/ccd.10713","article-title":"Migraine with aura related to the percutaneous closure of an atrial septal defect","volume":"60","author":"Rodes-Cabau","year":"2003","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ccl.2024.01.007_bib45","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1468-2982.2007.01331.x","article-title":"Migraine symptoms related to the percutaneous closure of an ostium secundum atrial septal defect: report of four paediatric cases and review of the literature","volume":"27","author":"Fernandez-Mayoralas","year":"2007","journal-title":"Cephalalgia"},{"key":"10.1016\/j.ccl.2024.01.007_bib46","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/eurheartj\/ehi170","article-title":"The influence of percutaneous atrial septal defect closure on the occurrence of migraine","volume":"26","author":"Mortelmans","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccl.2024.01.007_bib47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ccd.20268","article-title":"Transcatheter atrial septal defect closure with the Amplatzer septal occluder: five-year follow-up","volume":"64","author":"Yew","year":"2005","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ccl.2024.01.007_bib48","first-page":"357","article-title":"Efficacy of ticlopidine for preventing migraine after transcatheter closure of atrial septal defect with Amplatzer septal occluder: a case report","volume":"49","author":"Tomita","year":"2007","journal-title":"J\u00a0Cardiol"},{"issue":"15","key":"10.1016\/j.ccl.2024.01.007_bib49","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1177\/0333102412460778","article-title":"Atrial septal defect closure and de novo migraine: exclusive ticlopidine efficacy","volume":"32","author":"Benemei","year":"2012","journal-title":"Cephalalgia"},{"key":"10.1016\/j.ccl.2024.01.007_bib50","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/ccd.20144","article-title":"Efficacy of clopidogrel in the treatment of post-ASD closure migraines","volume":"63","author":"Sharifi","year":"2004","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ccl.2024.01.007_bib51","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1136\/hrt.2004.047746","article-title":"Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects","volume":"91","author":"Wilmshurst","year":"2005","journal-title":"Heart"},{"key":"10.1016\/j.ccl.2024.01.007_bib52","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1001\/jama.2015.13919","article-title":"Effect of clopidogrel and aspirin vs aspirin alone on migraine headaches after transcatheter atrial septal defect closure: the CANOA Randomized Clinical Trial","volume":"314","author":"Rodes-Cabau","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2024.01.007_bib53","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1177\/0333102414531156","article-title":"Clopidogrel as prophylactic treatment for migraine: a pilot randomised, controlled study","volume":"34","author":"Chambers","year":"2014","journal-title":"Cephalalgia"},{"key":"10.1016\/j.ccl.2024.01.007_bib54","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1177\/0333102414523845","article-title":"A\u00a0retrospective review of clopidogrel as primary therapy for migraineurs with right to left shunt lesions","volume":"34","author":"Spencer","year":"2014","journal-title":"Cephalalgia"},{"key":"10.1016\/j.ccl.2024.01.007_bib55","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1212\/WNL.0000000000006572","article-title":"Retrospective review of thienopyridine therapy in migraineurs with patent foramen ovale","volume":"91","author":"Sommer","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.ccl.2024.01.007_bib56","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1212\/WNL.0000000000006573","article-title":"Ticagrelor for refractory migraine\/patent foramen ovale (TRACTOR): an open-label pilot study","volume":"91","author":"Reisman","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.ccl.2024.01.007_bib57","first-page":"525","article-title":"Migraine in patients undergoing PFO closure: characterization of a platelet-associated pathophysiological mechanism: the LEARNER Study","volume":"7","author":"Trabattoni","year":"2022","journal-title":"J\u00a0Am Coll Cardiol Basic Transl Sci"}],"container-title":["Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865124000079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865124000079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T23:18:31Z","timestamp":1727133511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733865124000079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0733865124000079"],"URL":"https:\/\/doi.org\/10.1016\/j.ccl.2024.01.007","relation":{},"ISSN":["0733-8651"],"issn-type":[{"value":"0733-8651","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Migraine Headache and Patent Foramen Ovale","name":"articletitle","label":"Article Title"},{"value":"Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccl.2024.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}